{"DataElement":{"publicId":"2199745","version":"1","preferredName":"Reduced Platelet Agent Administered Code","preferredDefinition":"the code for the name of the anti-platelet agent being administered.","longName":"RED_PLT_AGT_ADM_CD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2199733","version":"1","preferredName":"Reduced Platelet  Agent Administered","preferredDefinition":"information related to the platelet-reducing agent being administered.","longName":"RED_PLT_AGT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2414807","version":"1","preferredName":"Reduced Platelet Agent","preferredDefinition":"Reduced; made less in size or amount or degree.:platelet. An irregularly shaped disklike cytoplasmic fragment of a megakaryocyte that is shed in the marrow sinus and subsequently found in the peripheral blood where it functions in clotting. A platelet contains granules in the central part (granulomere) and, peripherally, clear protoplasm (hyalomere), but no definite nucleus; is about one-third to one-half the size of an erythrocyte; and contains no hemoglobin. (STED98):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C25640:C12520:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Platelet","conceptCode":"C12520","definition":"An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02772734-9B00-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF9DAC66-60E4-24E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2199744","version":"1","preferredName":"Reduced Platelet Agent Code","preferredDefinition":"the code for the name of the anti-platelet agent.","longName":"RED_PLT_AGT_CD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"clopidogrel","ValueMeaning":{"publicId":"2573137","version":"1","preferredName":"clopidogrel","longName":"2573137","preferredDefinition":"clopidogrel","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EABE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"CAMPBELB","dateModified":"2005-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFADD711-611B-5E0E-E034-0003BA3F9857","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"ticlopidine","ValueMeaning":{"publicId":"2573138","version":"1","preferredName":"ticlopidine","longName":"2573138","preferredDefinition":"ticlopidine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EABF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"CAMPBELB","dateModified":"2005-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFADD711-611F-5E0E-E034-0003BA3F9857","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"dipyridamole","ValueMeaning":{"publicId":"2573139","version":"1","preferredName":"dipyridamole","longName":"2573139","preferredDefinition":"A drug that prevents blood cell clumping and enhances the effectiveness of fluorouracil and other chemotherapeutic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dipyridamole","conceptCode":"C445","definition":"A synthetic agent derivative of pyrimido-pyrimidine, with antiplatelet properties.  Dipyridamole inhibits adenosine uptake by platelets and endothelial cells, triggering an accumulation of cyclic adenosine monophosphate (cAMP), and inhibiting the stimulation of platelet aggregation by agents such as platelet activating factor and collagen. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EAC0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"REEVESD","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFADD711-6123-5E0E-E034-0003BA3F9857","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"99","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFADD711-6126-5E0E-E034-0003BA3F9857","beginDate":"2003-12-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184314","version":"1","preferredName":"Name","preferredDefinition":"A language unit by which a person or thing is known.","longName":"Name","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Person Name","conceptCode":"C25191","definition":"A word or group of words indicating the identity of a person usually consisting of a first (personal) name and a last (family) name with an optional middle name. In some cultural traditions the family name comes first.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E12-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFAF11E0-0C2E-5E1C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Agent code","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFAF6842-290C-5E12-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-09","modifiedBy":"CAMPBELB","dateModified":"2008-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}